4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide

C114H128N20O12S6 — CID 157057525

IUPAC4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide
SMILESCC(C)NS(=O)(=O)c1ccc(CCc2ccccc2)c(-c2cn(C)cn2)c1.CCNS(=O)(=O)c1ccc(CCc2ccccc2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ccccn2)c(-c2cn(C)cn2)c1.CC[C@@H](Cc1ccc(S(=O)(=O)NC)cc1-c1cn(C)cn1)c1ccccc1.Cn1cnc(-c2cc(S(C)(=O)=O)ccc2NCc2ccccc2)c1.Cn1cnc(-c2cc(S(N)(=O)=O)ccc2NCc2ccccc2)c1
InChIInChI=1S/2C21H25N3O2S.C20H23N3O2S.C18H19N3O2S.2C17H18N4O2S/c1-16(2)23-27(25,26)19-12-11-18(10-9-17-7-5-4-6-8-17)20(13-19)21-14-24(3)15-22-21;1-4-16(17-8-6-5-7-9-17)12-18-10-11-19(27(25,26)22-2)13-20(18)21-14-24(3)15-23-21;1-3-22-26(24,25)18-12-11-17(10-9-16-7-5-4-6-8-16)19(13-18)20-14-23(2)15-21-20;1-21-12-18(20-13-21)16-10-15(24(2,22)23)8-9-17(16)19-11-14-6-4-3-5-7-14;1-21-11-17(20-12-21)15-9-14(24(18,22)23)7-8-16(15)19-10-13-5-3-2-4-6-13;1-3-24(22,23)13-7-8-15(20-17-6-4-5-9-18-17)14(10-13)16-11-21(2)12-19-16/h4-8,11-16,23H,9-10H2,1-3H3;5-11,13-16,22H,4,12H2,1-3H3;4-8,11-15,22H,3,9-10H2,1-2H3;3-10,12-13,19H,11H2,1-2H3;2-9,11-12,19H,10H2,1H3,(H2,18,22,23);4-12H,3H2,1-2H3,(H,18,20)/t;16-;;;;/m.0..../s1
InChIKeyAAXXDRFAOJREHX-NKLKMKEXSA-N
MW2162.81 g/mol
LogP18.93
Rot. Bonds36

About 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide

4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide (PubChem CID 157057525) has the molecular formula C114H128N20O12S6 and a molecular weight of 2162.81 g/mol. Its IUPAC name is 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide.

Molecular Properties

Compound Name4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide
PubChem CID157057525
Molecular FormulaC114H128N20O12S6
Molecular Weight2162.81 g/mol
Exact Mass2160.83
IUPAC Name4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide
SMILESCC(C)NS(=O)(=O)c1ccc(CCc2ccccc2)c(-c2cn(C)cn2)c1.CCNS(=O)(=O)c1ccc(CCc2ccccc2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ccccn2)c(-c2cn(C)cn2)c1.CC[C@@H](Cc1ccc(S(=O)(=O)NC)cc1-c1cn(C)cn1)c1ccccc1.Cn1cnc(-c2cc(S(C)(=O)=O)ccc2NCc2ccccc2)c1.Cn1cnc(-c2cc(S(N)(=O)=O)ccc2NCc2ccccc2)c1
InChIInChI=1S/2C21H25N3O2S.C20H23N3O2S.C18H19N3O2S.2C17H18N4O2S/c1-16(2)23-27(25,26)19-12-11-18(10-9-17-7-5-4-6-8-17)20(13-19)21-14-24(3)15-22-21;1-4-16(17-8-6-5-7-9-17)12-18-10-11-19(27(25,26)22-2)13-20(18)21-14-24(3)15-23-21;1-3-22-26(24,25)18-12-11-17(10-9-16-7-5-4-6-8-16)19(13-18)20-14-23(2)15-21-20;1-21-12-18(20-13-21)16-10-15(24(2,22)23)8-9-17(16)19-11-14-6-4-3-5-7-14;1-21-11-17(20-12-21)15-9-14(24(18,22)23)7-8-16(15)19-10-13-5-3-2-4-6-13;1-3-24(22,23)13-7-8-15(20-17-6-4-5-9-18-17)14(10-13)16-11-21(2)12-19-16/h4-8,11-16,23H,9-10H2,1-3H3;5-11,13-16,22H,4,12H2,1-3H3;4-8,11-15,22H,3,9-10H2,1-2H3;3-10,12-13,19H,11H2,1-2H3;2-9,11-12,19H,10H2,1H3,(H2,18,22,23);4-12H,3H2,1-2H3,(H,18,20)/t;16-;;;;/m.0..../s1
InChIKeyAAXXDRFAOJREHX-NKLKMKEXSA-N
XLogP18.93
TPSA422.85 Ų
H-Bond Donors7
H-Bond Acceptors28
Rotatable Bonds36
Heavy Atoms152
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002162.81
LogP ≤ 518.93
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1028

Analyze 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-benzyl-2-(1-cyclopropylimidazol-4-yl)-4-ethylsulfonylaniline;N-benzyl-4-ethylsulfonyl-2-(1-propan-2-ylimidazol-4-yl)aniline;(1R)-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-1,2,3,4-tetrahydronaphthalen-1-amine;N-[2-(1-methylimidazol-4-yl)-4-methylsulfonylphenyl]-4-(trifluoromethyl)pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-[[4-(trifluoromethyl)-2-pyridinyl]amino]benzenesulfonamide
CID 157173167
N-[2-(1-cyclopropylimidazol-4-yl)-4-ethylsulfonylphenyl]-4-(trifluoromethyl)pyridin-2-amine;(1S)-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-1,2,3,4-tetrahydronaphthalen-1-amine;N-[4-ethylsulfonyl-2-(1-propan-2-ylimidazol-4-yl)phenyl]-4-(trifluoromethyl)pyridin-2-amine;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2R)-2-phenylbutyl]benzenesulfonamide
CID 157539772
5-ethylsulfonyl-3-(1-methylimidazol-4-yl)-N-(1-phenylethyl)pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridin-2-amine;N-(4-ethylsulfonyl-2-pyridin-2-ylphenyl)-5-(trifluoromethyl)pyridin-2-amine;4-(3-hydroxy-2-phenylpropyl)-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide
CID 157640764
N-ethyl-3-(1-methylimidazol-4-yl)-4-[[4-(trifluoromethyl)-2-pyridinyl]amino]benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyridin-2-amine;4-[(2R)-3-hydroxy-2-phenylpropyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;4-[(2S)-3-hydroxy-2-phenylpropyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide
CID 157835172
N-[1-[3-(1,1-difluoroethyl)phenyl]ethyl]-4-ethylsulfonyl-2-(1-methylimidazol-4-yl)aniline;4-(2,3-dihydro-1H-inden-1-ylamino)-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-1,2,3,4-tetrahydronaphthalen-1-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[1-[4-(trifluoromethyl)phenyl]ethyl]aniline;N-methyl-3-(1-methylimidazol-4-yl)-4-(2-phenylbutyl)benzenesulfonamide
CID 157984840
4-[2-(1,3-benzothiazol-5-yl)ethyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-(1,3-benzothiazol-6-ylmethyl)-4-ethylsulfonyl-2-(1-methylimidazol-4-yl)aniline;N-[2-(1-benzylimidazol-4-yl)-4-ethylsulfonylphenyl]-5-(trifluoromethyl)pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridin-3-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]aniline
CID 158442554
5-tert-butyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-[1-[(2-fluorophenyl)methyl]imidazol-4-yl]phenyl]-5-(trifluoromethyl)pyridin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[4-(trifluoromethyl)phenyl]aniline;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[(1S)-1-[3-(trifluoromethyl)phenyl]ethyl]aniline
CID 159363475
methane;bis(4-[(2R)-1-methylpyrrolidin-2-yl]-1-[4-(3-methylsulfonylphenyl)phenyl]-2-[2-(trifluoromethyl)phenyl]imidazole);1-[4-(3-methylsulfonylphenyl)phenyl]-4-[(2R)-pyrrolidin-2-yl]-2-[2-(trifluoromethyl)phenyl]imidazole
CID 160207904
5-ethylsulfonyl-3-(1-methylimidazol-4-yl)-N-[(1R)-1-phenylethyl]pyridin-2-amine;5-ethylsulfonyl-3-(1-methylimidazol-4-yl)-N-[(1S)-1-phenylethyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-4-(trifluoromethyl)pyridin-2-amine;5-ethylsulfonyl-3-(1-methylimidazol-4-yl)-N-[3-(trifluoromethyl)phenyl]pyridin-2-amine
CID 161588099
3-(1-cyclopropylimidazol-4-yl)-4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;3-(1-cyclopropylimidazol-4-yl)-4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[3-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-methyl-3-(2-methyltetrazol-5-yl)-4-(4-phenylanilino)benzenesulfonamide
CID 163422069
4-[4-(1,1-difluoroethyl)anilino]-3-(1-ethylimidazol-4-yl)-N-methylbenzenesulfonamide;4-[[4-(1,1-difluoroethyl)phenyl]methyl]-N-methyl-3-(1-methylimidazol-4-yl)benzenesulfonamide;4-[(4-fluoro-3-methylphenyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;4-[(2-fluorophenyl)methyl]-N-methyl-3-(2-methyltetrazol-5-yl)benzenesulfonamide;N-methyl-4-[(4-methylphenyl)methyl]-3-(1-methyltetrazol-5-yl)benzenesulfonamide;N-methyl-4-[(4-methylphenyl)methyl]-3-(2-methyltetrazol-5-yl)benzenesulfonamide
CID 163685257
N-benzyl-2-(1-cyclopropylimidazol-4-yl)-4-ethylsulfonylaniline;4-ethylsulfonyl-N-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]-2-(1-methylimidazol-4-yl)aniline;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]aniline
CID 163822053

Frequently Asked Questions

What is the IUPAC name of 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide?
The IUPAC name of 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide (CID 157057525) is 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide.
What is the SMILES notation for 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide?
The canonical SMILES for 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide is CC(C)NS(=O)(=O)c1ccc(CCc2ccccc2)c(-c2cn(C)cn2)c1.CCNS(=O)(=O)c1ccc(CCc2ccccc2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ccccn2)c(-c2cn(C)cn2)c1.CC[C@@H](Cc1ccc(S(=O)(=O)NC)cc1-c1cn(C)cn1)c1ccccc1.Cn1cnc(-c2cc(S(C)(=O)=O)ccc2NCc2ccccc2)c1.Cn1cnc(-c2cc(S(N)(=O)=O)ccc2NCc2ccccc2)c1.
What is the InChIKey of 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide?
The InChIKey is AAXXDRFAOJREHX-NKLKMKEXSA-N. The full InChI is InChI=1S/2C21H25N3O2S.C20H23N3O2S.C18H19N3O2S.2C17H18N4O2S/c1-16(2)23-27(25,26)19-12-11-18(10-9-17-7-5-4-6-8-17)20(13-19)21-14-24(3)15-22-21;1-4-16(17-8-6-5-7-9-17)12-18-10-11-19(27(25,26)22-2)13-20(18)21-14-24(3)15-23-21;1-3-22-26(24,25)18-12-11-17(10-9-16-7-5-4-6-8-16)19(13-18)20-14-23(2)15-21-20;1-21-12-18(20-13-21)16-10-15(24(2,22)23)8-9-17(16)19-11-14-6-4-3-5-7-14;1-21-11-17(20-12-21)15-9-14(24(18,22)23)7-8-16(15)19-10-13-5-3-2-4-6-13;1-3-24(22,23)13-7-8-15(20-17-6-4-5-9-18-17)14(10-13)16-11-21(2)12-19-16/h4-8,11-16,23H,9-10H2,1-3H3;5-11,13-16,22H,4,12H2,1-3H3;4-8,11-15,22H,3,9-10H2,1-2H3;3-10,12-13,19H,11H2,1-2H3;2-9,11-12,19H,10H2,1H3,(H2,18,22,23);4-12H,3H2,1-2H3,(H,18,20)/t;16-;;;;/m.0..../s1.
What are the key properties of 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide?
4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide has a molecular weight of 2162.81 g/mol, XLogP of 18.93, 36 rotatable bonds, 7 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(benzylamino)-3-(1-methylimidazol-4-yl)benzenesulfonamide;N-benzyl-2-(1-methylimidazol-4-yl)-4-methylsulfonylaniline;N-ethyl-3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)benzenesulfonamide;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;3-(1-methylimidazol-4-yl)-4-(2-phenylethyl)-N-propan-2-ylbenzenesulfonamide;N-methyl-3-(1-methylimidazol-4-yl)-4-[(2S)-2-phenylbutyl]benzenesulfonamide is sourced from PubChem (CID 157057525), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).